| Typicality: | 0.417 |
| Saliency: | 0.391 |
| with a third cohort | 5 | other |
| on about 700 patients | 5 | location |
| in the new study | 4 | location |
| researcher → test → the method | 35 |
| researcher → tested → the method | 3 |
| researcher → test → this method | 3 |
| negative | neutral | positive |
| 0.051 | 0.718 | 0.230 |
| Raw frequency | 41 |
| Normalized frequency | 0.391 |
| Modifier score | 0.500 |
| Perplexity | 189.385 |